Doctoral Course: From Research to ATMP Treatment

Karolinska Institutet offers a two-week doctoral course providing a comprehensive overview of the full journey from early research to GMP-compliant manufacturing of cell and gene therapy products.
The course covers key aspects such as process development, quality assurance, regulatory frameworks, and logistics – all essential for translating innovative ATMPs from the lab to patients.
During the course students will gain insight into establishing standard operating procedures (SOPs) for the production of cell and gene therapy products, and how to validate product purity and function. They will learn to understand differences between process development within pre-GMP and GMP and transfer of SOP from pre-GMP to GMP. They will also learn to understand differences/similarities between pre-GMP and GMP and the regulatory requirements that exist within ATMP. The students will also obtain an overview of both regulatory regulations and legal aspects of ATMP products.
Upon successful completion of the course, students will have acquired basic knowledge of how to set up production of a cell or gene therapy product according to good manufacturing practice (GMP).

📍 On site at ANA Futura, KI Campus South
🗓 12–23 October 2026 (Weeks 42–43)
📝 Application period: 15 April – 6 May 2026
Course Lecturers:
Gustaf Ahlén, Department of Laboratory Medicine, Karolinska Institutet, Division of Clinical Microbiology: gustaf.ahlen@ki.se

The course is primarily aimed at PhD students within the National ATMP Research School, with a limited number of places available for other KI doctoral students interested in ATMPs.

💡 Good news for industry:
A company-focused version of this course is planned for next spring – stay tuned!

👉 Apply via the KI Course Catalogue for doctoral courses.
📸 Photo: Liza Simonsson